THEMISMED - Themis Medicare

Themis Medicare

THEMISMED · Pharma > Pharmaceuticals & Drugs · Chairman: Hoshang N Sinor · MD: Sachin D Patel · Listing date: April 2, 2007 · Employees: 976 · Mumbai · http://www.themismedicare.com

Stock Price vs Company Growth

2.2%

1.6%

5.8%

5.7%

49.1%

41.1%

53.0%

10y

42.6%

all

18.5%

🤔 How to analyze this graph?

Last Traded Price

₹ 217 2.2%

193

266

Company Overview

Sales

364 Cr

Growth: 5.4%

Profit after Tax

45.3 Cr

Growth: -11.6%

Small Cap

1,995 Cr

P/E: 44.1x

Industry P/E: 34.5x

Fundamentals

Sales (Cr)	₹ 364
Growth	5.4%
EBITDA	14.5%
P/S	5.5x
Dividend	0.3%
P/E	44.1x
Book Value	₹ 37.2
PEG Ratio	8.2x
ROE	13.9%
P/B	5.8x

Shareholding Pattern

Institutions

Anuj Anantrai Sheth

4.89 %

Zafar Ahmadullah

1.76 %

Za Capital Services India Private Ltd

1.29 %

Iepf

0.34 %

Promoters

Vividhmargi Investments Private Ltd.

15.8 %

Gedeon Richter Investment Management Ltd.

9.62 %

Dinesh Shantilal Patel

9.49 %

Vividh Distributors Private Ltd.

7.79 %

Jayshree D Patel

7.26 %

Others

Increase Decrease No change

Company Profile Detailed

Themis Medicare (TML) incorporated in 1969, is engaged in manufacturing of Active Pharmaceutical Ingredients (APIs) and Formulations. Erstwhile known as Themis Chemical the company is promoted by Mr. Shantibhai D. Patel. It is joint venture with Gedeon Richter, Hungary.Headquartered in Mumbai, the company has four manufacturing facilities located at Vapi (Gujarat), Hyderabad (Andhra Pradesh), and Haridwar (Uttaranchal).

Belongs to (4 Indices)

Investors (51)

zafar.ah...

iepf

urjita.j...

Followers (2)

vinodgow...

tejasdod...